{"schema_version":"1","generated_at":"2026-11-22T01:30:01.134Z","data_as_of":null,"url":"https://www.findmykol.com/kol/monica-yang","json_url":"https://www.findmykol.com/kol/monica-yang/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"monica-yang","name":"Monica Yang","credential":"MD","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"University of California, San Francisco","institution_url":"https://www.findmykol.com/institution/university-of-california-san-francisco","city":"San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Monica Yang is a Rheumatology/Immunology physician affiliated with University of California, San Francisco. OpenAlex indexes 30 publications with 626 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":30,"cited_by_count":626,"h_index":7,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2024,"amount_usd":118.02,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":3,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":56.1,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":56.1,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":15}]},{"area":"Cancer & immunology","share_pct":35.5,"classes_total":3,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":16.8,"drugs":[{"name":"Rasuvo","share_pct":100}],"max_beneficiaries":null},{"class":"Interleukin-17A Antagonist","setting":"prescribed","share_pct":11,"drugs":[{"name":"Cosentyx Sensoready (2 Pens)","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":8.4,"classes_total":1,"classes":[{"class":"Sulfone","setting":"prescribed","share_pct":8.4,"drugs":[{"name":"Dapsone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":30,"shown":5,"withheld":25,"matched_by":"OpenAlex author record","recent":[{"title":"Immune profiling links autoimmune hepatitis to human herpesvirus 6 and relaxin receptor antigens","year":2026,"journal":"The Journal of Experimental Medicine","source_url":"https://doi.org/10.1084/jem.20250959","status":"verified"},{"title":"Circulating CTHRC1 levels are associated with IPF disease severity and survival","year":2026,"journal":"Thorax","source_url":"https://doi.org/10.1136/thorax-2025-224557","status":"verified"},{"title":"Nintedanib and Pirfenidone Affect Growth and Differentiation of Human Alveolar Type 2 Cells","year":2026,"journal":"bioRxiv (Cold Spring Harbor Laboratory)","source_url":"https://doi.org/10.64898/2026.03.02.708135","status":"verified"},{"title":"Exposure to autoimmune disorders is associated with increased Alzheimer’s disease risk in a multi-site electronic health record analysis","year":2025,"journal":"Cell Reports Medicine","source_url":"https://doi.org/10.1016/j.xcrm.2025.101980","status":"verified"},{"title":"Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis","year":2025,"journal":"Arthritis & Rheumatology","source_url":"https://doi.org/10.1002/art.43400","status":"verified"}],"source":"works"},"similar":[{"name":"Kristine Yaffe","slug":"kristine-yaffe","institution":"University of California, San Francisco","specialty":"Geriatric Psychiatry","url":"https://www.findmykol.com/kol/kristine-yaffe","json_url":"https://www.findmykol.com/kol/kristine-yaffe/profile.json"},{"name":"Peter Carroll","slug":"peter-carroll","institution":"University of California, San Francisco","specialty":"Urology","url":"https://www.findmykol.com/kol/peter-carroll","json_url":"https://www.findmykol.com/kol/peter-carroll/profile.json"},{"name":"Steven Deeks","slug":"steven-deeks","institution":"University of California, San Francisco","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/steven-deeks","json_url":"https://www.findmykol.com/kol/steven-deeks/profile.json"},{"name":"Michael Shlipak","slug":"michael-shlipak","institution":"University of California, San Francisco","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/michael-shlipak","json_url":"https://www.findmykol.com/kol/michael-shlipak/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":25}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}